SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology IGFBP3 products
includes other brands or spellings
|
| ih | | Santa Cruz Biotechnology antibody against IGFBP3 was used in immunohistochemistry to investigate IGFBP3 expression in human nonmetastatic and metastatic well-differentiated pancreatic endocrine neoplasms. |
| ip, wb | | Santa Cruz Biotechnology rabbit polyclonal anti-IGFBP-3 antibody R-30 and goat polyclonal anti-IGFBP-3 antibody C-19 were respectively used in immunoprecipitation, western blot and western blot to study the interactions between amino- and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 and IGFs. |
BD BIOSCIENCES search BD Biosciences IGFBP3 products
includes other brands or spellings
|
| wb | | BD Transduction IGFBP-3 antibody was tested in western blot by Abminer. |
MILLIPORE search Millipore IGFBP3 products
includes other brands or spellings
|
| ic | | Upstate Biotechnology rabbit anti-IGFBP-3 antibody was used in human retinal endothelial cells and in immunocytochemistry to study the expression of IGFBP-3 in human retinal endothelial cells and the role of IGFBP-3 in growth inhibition and apoptosis. |
| wb | | Upstate Biotechnology anti-IGFBP-3 anti-serum was used in western blot to study the interaction of insulin-like growth factor II (IGF-II) with multiple plasma protein. |
DIAGNOSTIC SYSTEMS LABORATORIES
|
| wb | | Diagnostic Systems Laboratories monoclonal anti-hIGFBP-3 antibody 3 (which recognizes N terminal amino acids 1-97 of hIGFBP-3) and antibody 1 (which recognizes C terminal residues 98-264 of hIGFBP-3) were used in cultured cells with 795-nucleotide coding region of hIGFBP-3 cDNA and in western blot to study the contributions of IGF-independent mechanisms to growth inhibition by IGFBP-3. |
| wb | | Diagnostic Systems Laboratories anti-IGFBP-3 antibody was used in human PC-3 cells and in western blot to study the role of IGFBP-3 for TNF- -induced apoptosis. |
Articles Reviewed |
| 1. Jiang Hong et al. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. 2002 |
| 2. Roopmathy Rajah et al. Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: role of Bcl-2 phosphorylation. 2002 |
| 3. Polyxenie E Spoerri et al. Expression of IGFBP-3 by human retinal endothelial cell cultures: IGFBP-3 involvement in growth inhibition and apoptosis. 2003 |
| 4. Louis D Payet et al. Amino- and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 cooperate to bind IGFs with high affinity and inhibit IGF receptor interactions. 2003 |
| 5. Donna E Hansel et al. Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms. 2004 |
| 6. Sandra Oesterreicher et al. Interaction of insulin-like growth factor II (IGF-II) with multiple plasma proteins: high affinity binding of plasminogen to IGF-II and IGF-binding protein-3. 2005 |
| 7. Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |